A subset of women from the Women's Health Study, a randomized, double-blind, placebo-controlled trial, participated in a study to determine if 600 IU of ?-tocopherol taken on alternate days has any effects on general cognition, verbal memory, or category fluency in generally healthy older women.
A subset of women from the Women's Health Study, a randomized, double-blind, placebo-controlled trial, participated in a study to determine if 600 IU of α-tocopherol taken on alternate days has any effects on general cognition, verbal memory, or category fluency in generally healthy older women.
Unfortunately, data from 10 years of treatment and 4 years of follow-up revealed no indication that vitamin E provides any overall cognitive benefits. At each cognitive assessment (the first at 5.6 years after randomization and the last at 9.6 years), the researchers observed no differences in global scores between the vitamin E and placebo groups. And the risk for substantial decline in the global score in the vitamin E group versus the placebo group was 0.92 (95% CI, 0.77–1.10).
The authors say the lack of findings could be due to the dose of vitamin E being too low, that the supplements used in the study contained mostly α-tocopherols, rather than γ-tocopherols, which may be more beneficial, or that the duration of use, although long in the study, was insufficient. Perhaps the supplements must be started prior to the sixth decade of life. Vitamin E supplementation for 10 years or less does not seem to provide any sort of neuroprotection.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More